Zosano Pharma is a private pharmaceutical company founded in October 2006 and is focused on creating better products with their innovative drug delivery technology.
Their lead program, parathyroid hormone (PTH) transdermal microprojection delivery system has finalized a Phase 2 clinical trial for treating severe osteoporosis. Zosano's objective is to discover and develop therapeutic drug candidates which address large unmet medical needs or have a significant potential for commercialization.
Current Team (5)Update
Past Team (2)Update
Funding Rounds (7) - $142.4MUpdate
Board Members and Advisors (4)Update
securities broker and private equity
Global venture capital firm helping entrepreneurs build transformational businesses across...
LIfe Sciences Venture Firm
As a venture capital company, HBM BioVentures is invested globally in some 40 mature emerging...
34790 Ardentech Court
Fremont, CA 94555